We found that the high mRNA expression of MMP9 correlated with an unfavorable clinical outcome of ccRCC patients (Supplemental Information 3), after adjusting for tumor location, stage and patient age, gender and race (Table 2). This evidence concerns the gene MMP9 and nonpapillary renal cell carcinoma.